The Landscape of Diabetes Research in America
More than 40 million Americans live with diabetes, and roughly 1.5 million new diagnoses happen each year. Behind those numbers are researchers working overtime to find better options. The result? A robust pipeline of clinical trials spread across the country, from Stanford's Diabetes Research Center in California to Boston Children's Hospital on the East Coast.
What's being studied right now is genuinely exciting. Vertex Pharmaceuticals is evaluating VX-880, an islet cell replacement therapy for people with type 1 diabetes who struggle with hypoglycemia unawareness. Eli Lilly recently launched the BARICADE-DELAY study, testing whether baricitinib can delay the onset of clinical type 1 diabetes in at-risk children and adults. And the STEP-1 study at Brigham & Women's Hospital in Boston is testing an endoscopic device designed to improve blood sugar control in people with type 2 diabetes who haven't reached their targets with oral medications.
But here's what most people don't realize: clinical trials need participants as much as participants need better treatments. Many studies struggle to meet enrollment goals, which delays research and pushes potentially life-changing therapies further into the future.
Who Can Participate and What to Expect
The Eligibility Question
Every study operates with specific criteria, and they vary widely. A GLP-1 trial in Los Angeles County might look for adults 18 and older with type 2 diabetes, an A1c between 7 and 11, and no prior use of insulin or GLP-1 medications in the past six months. A diet study at Boston Children's Hospital might target young adults with type 1 diabetes willing to follow either a standard diet or a very low carbohydrate diet for a set period.
The good news? You don't need to be a patient at the research hospital to enroll. Boston Children's, for example, explicitly welcomes participants from outside their existing patient base. What matters is whether you meet the study's specific inclusion and exclusion criteria, which are published on each trial's ClinicalTrials.gov page.
What Participation Looks Like
Clinical trials aren't one-size-fits-all. Some require you to visit a clinic regularly over several months. Others are largely digital, using wearables and apps to track your glucose, meals, and sleep from home.
Take the VITAL-CGM study at Stanford. It pairs a virtual weight control program with continuous glucose monitoring for adults with type 2 diabetes. Participants get free access to a diabetes-tailored Weight Watchers app for 12 months, continuous glucose monitors, and virtual group sessions with trained professionals. That's a study you can do mostly from your living room.
Compare that with the STEP-1 study, which involves an outpatient endoscopic procedure under general anesthesia to place an investigational device in the small intestine. Participants stay in the study for about 21 months, attend at least 15 in-person visits, and track their glucose and temperature daily in an electronic diary.
Before you enroll in any study, the research team walks you through a process called informed consent. They explain the purpose, the procedures, potential risks, and your rights. You can withdraw at any time for any reason, without penalty and without affecting your future medical care.
What About Compensation?
Compensation is a common question, and it varies considerably by study. Some trials pay per visit, often in the range of $50 to $150 per appointment. Others offer a lump sum for completing the full study. A type 1 diabetes diet study at Boston Children's Hospital pays up to $1,300 for time and effort, with all meals provided by a delivery service. A GLP-1 study in LA County offers $150 per visit plus a $500 bonus for completing the entire trial. Longer, more intensive studies can pay more, with some diabetes trials offering up to $5,000 or more over the course of the research.
It's worth understanding that compensation reflects the time commitment and burden of the study, not the value of your contribution. And regardless of compensation, participation is completely voluntary. You should never feel pressured to enroll, and you can leave at any time.
A Closer Look at Current Study Options
| Study | Focus | Typical Participants | Time Commitment | Compensation Range | Key Advantages | What to Consider |
|---|
| VITAL-CGM (Stanford) | Virtual weight loss + CGM for type 2 diabetes | Ages 18-69 with type 2 diabetes | 12 months, mostly remote | $50-$75 per visit | Free CGM and Weight Watchers app, minimal travel | Requires willingness to engage with virtual coaching |
| STEP-1 (Boston, Ann Arbor, Baylor) | Endoscopic duodenal device for uncontrolled type 2 diabetes | Ages 22-65, A1c 7.5-10, BMI 30-50 | About 21 months, 15+ visits | Travel expense compensation | Investigational device with promising early results | Invasive procedure under anesthesia, blinded study design |
| GLP-1 Study (LA County) | GLP-1 medication for weight loss and glucose control | Adults 18+, type 2 diabetes, no recent GLP-1/insulin use | Varies by study arm | $150 per visit plus $500 completion bonus | Open-label extension means everyone gets the medication | Must be an LA County resident |
| Boston Children's Diet Study | Standard vs. very low carbohydrate diets in type 1 diabetes | Young adults with type 1 diabetes | Several weeks of meal delivery | Up to $1,300 | All meals and snacks provided free | Random assignment means you don't choose your diet |
| BARICADE-DELAY (Eli Lilly) | Baricitinib to delay type 1 diabetes onset in at-risk individuals | Children and adults at high risk for type 1 diabetes | Up to 5 years | Compensation per visit | Could delay or prevent diabetes onset | Long-term commitment, requires regular monitoring |
How to Find the Right Trial for You
Step 1: Start with ClinicalTrials.gov
This is the official database maintained by the U.S. National Library of Medicine. It lists every registered clinical trial in the country, along with eligibility criteria, study locations, contact information, and current recruitment status. You can filter by condition, location, age group, and study phase. If a study is recruiting, it will say so right on the page.
Step 2: Talk to Your Doctor
Your healthcare team knows your medical history better than anyone. Ask whether they're aware of relevant trials in your area, or bring them a list of studies you've found and ask for their honest assessment. The American Diabetes Association recommends starting with your doctor, noting that they can advise whether a research study is a good fit for your particular situation.
Step 3: Use Diabetes Organizations as a Bridge
Groups like the American Diabetes Association and Taking Control of Your Diabetes (TCOYD) regularly highlight active trials and can connect you with research coordinators. TCOYD, for example, maintains a database of trials specifically for people with type 1 and type 2 diabetes and provides plain-language explanations of what each study involves.
Step 4: Screen Carefully
When you find a study that looks promising, complete the pre-screening questionnaire honestly. Research teams will verify your medical history during a formal screening visit, which typically includes blood work, a physical exam, and a review of your current medications. Being upfront about your health status protects both you and the integrity of the research.
Step 5: Ask the Right Questions
Before you sign anything, make sure you understand the time commitment, the number of visits, whether travel is reimbursed, what procedures are involved, and whether the study uses a placebo or a blinded design. Ask about the follow-up care you'll receive after the study ends, and confirm that your regular diabetes care continues uninterrupted.
Real People, Real Results
Take the story of a participant in the Boston Children's diet study. She enrolled partly out of curiosity about how carbohydrate intake affects her glucose levels and partly because she wanted her experience to inform future care for others with type 1 diabetes. Over the course of the study, she gained a much clearer picture of how her body responds to different meals, and she left with practical insights she now applies every day.
Or consider a participant in the Stanford VITAL-CGM study, who described the free continuous glucose monitor as "the most eye-opening tool I've ever used." Seeing real-time glucose responses to different foods and activities transformed how she approached her daily routine, even before she saw the final study results.
These are the quieter rewards of participation. Beyond the compensation and the chance to access investigational treatments, there's the value of learning more about your own body and knowing you're contributing to research that will help millions of people.
Making Your Decision
Participating in a diabetes clinical trial is a personal decision that deserves careful thought. It's not for everyone, and that's okay. But if you're curious about new approaches, frustrated with your current options, or simply want to give back to a community that's been researching this disease for decades, there's likely a study out there that fits your circumstances.
Start with a conversation with your doctor. Browse ClinicalTrials.gov with an open mind. Reach out to study coordinators with your questions. And remember that every study you consider will walk you through the informed consent process, where you'll have the chance to ask anything before making a commitment.
The landscape of diabetes care is changing faster than ever, and the people enrolled in these trials today are helping shape the treatments of tomorrow. That's a meaningful role to play, whatever your reason for stepping in.
研究の知恵